Revolution Medicines, Inc. · NASDAQ:RVMD
Kelsey Stephen Michael sold 27,160 Revolution Medicines, Inc. shares (Form 4)
Traded Nov 16, 2026 · Filed Nov 18, 2026
On Nov 16, 2026, Kelsey Stephen Michael (See Remarks) sold 27,160 Revolution Medicines, Inc. shares at an average US$167.86 for US$4.56M under a trading plan, leaving 286,307 shares. Filed Nov 18, 2026 (Form 4).
- Sold
- 27,160 shares
- Price
- US$167.86 average (US$166.75 to US$171.65)
- Value
- US$4.56M
- Holding after
- 286,307 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Stock | Option exercise | 27,160 | US$18.56 | 313,467 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 11,542 | US$166.75 | 301,925 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 3,627 | US$167.66 | 298,298 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 8,039 | US$168.64 | 290,259 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 3,052 | US$169.46 | 287,207 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 700 | US$170.40 | 286,507 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 200 | US$171.65 | 286,307 | Direct |
Source
Download original · View original at SEC
Related
- Revolution Medicines, Inc.
- Kelsey Stephen Michael
- Revolution Medicines, Inc. shareholders
- Form 4 · Kelsey Stephen Michael · Sep 18, 2026
- Form 4 · Kelsey Stephen Michael · Sep 15, 2026
- Form 4 · Kelsey Stephen Michael · Jun 18, 2026
- Form 4 · Borellini Flavia · Nov 17, 2026
- Schedule 13G/A · Baker Bros. Advisors LP · Nov 16, 2026
- Schedule 13G/A · Janus Henderson Group Ltd. · Nov 16, 2026
- Form 4 · Anders Jack · Nov 13, 2026
- Form 4 · Borisy Alexis · Nov 13, 2026